Details for 2020179813

Up to date per 02.04.2026

Actions

Title / Product Name

AZETIDIN ABKÖMMLINGE ALS FXR(NR1H4)-MODULIERENDE VERBINDUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020179813

EP Publication Number

3730487

E-Number

1486876

Language

PCT Number

Publication Date

28.10.2020 A

27.04.2022 B1

Registration Date

27.04.2022

AT Publication Date

15.05.2022

Application Date

09.06.2017

Registration Number

Priorities

13.06.2016

201662349479 P

IPC

C07D 401/14 20060101AFI20200728BHEP

Maximum Duration of Protection

09.06.2037

Owner

Gilead Sciences, Inc.333 Lakeside Drive Foster City, CA 94404US

Representative

Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT

Inventor

BLOMGREN, Peter Ac/o Gilead Sciences, Inc. 333 Lakeside Drive Foster City, California 94404US

CURRIE, Kevin Sc/o Gilead Sciences, Inc. 333 Lakeside Drive Foster City, California 94404US

FARAND, Juliec/o Gilead Sciences, Inc. 333 Lakeside Drive Foster City, California 94404US

GEGE, Christianc/o Phenex Pharmaceuticals AG Donnersbergweg 1 67059 LudwigshafenDE

KROPF, Jeffrey Ec/o Gilead Sciences, Inc. 333 Lakeside Drive Foster City, California 94404US

XU, Jianjunc/o Gilead Sciences, Inc. 333 Lakeside Drive Foster City, California 94404US

Information about Fees